Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie D Croxtall

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
CNS Drugs|February 3, 2012
Aripiprazole: a review of its use in the management of schizophrenia in adultsJamie D Croxtall
Paediatric Drugs|September 6, 2011
Clonidine extended-release: in attention-deficit hyperactivity disorderJamie D Croxtall
CNS Drugs|January 18, 2012
Clonidine extended-release in attention-deficit hyperactivity disorder: profile reportJamie D Croxtall
American Journal of Clinical Dermatology|December 29, 2011
Spotlight on ustekinumab in moderate to severe plaque psoriasisJamie D Croxtall
Drugs|September 10, 2011
Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasisJamie D Croxtall
Paediatric Drugs|March 28, 2012
Valsartan: in children and adolescents with hypertensionJamie D Croxtall
Drugs|March 30, 2011
Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers)Jamie D Croxtall
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 28, 2011
Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile reportJamie D Croxtall
Drugs|October 23, 2010
Lidocaine/tetracaine medicated plaster: in minor dermatological and needle puncture proceduresJamie D Croxtall
Drugs|May 17, 2011
Rituximab: as first-line maintenance therapy following rituximab-containing therapy for follicular lymphomaJamie D Croxtall
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
CNS Drugs|February 3, 2012
Aripiprazole: a review of its use in the management of schizophrenia in adultsJamie D Croxtall
Paediatric Drugs|September 6, 2011
Clonidine extended-release: in attention-deficit hyperactivity disorderJamie D Croxtall
CNS Drugs|January 18, 2012
Clonidine extended-release in attention-deficit hyperactivity disorder: profile reportJamie D Croxtall
American Journal of Clinical Dermatology|December 29, 2011
Spotlight on ustekinumab in moderate to severe plaque psoriasisJamie D Croxtall
Drugs|September 10, 2011
Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasisJamie D Croxtall
Paediatric Drugs|March 28, 2012
Valsartan: in children and adolescents with hypertensionJamie D Croxtall
Drugs|March 30, 2011
Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers)Jamie D Croxtall
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 28, 2011
Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile reportJamie D Croxtall
Drugs|October 23, 2010
Lidocaine/tetracaine medicated plaster: in minor dermatological and needle puncture proceduresJamie D Croxtall
Drugs|May 17, 2011
Rituximab: as first-line maintenance therapy following rituximab-containing therapy for follicular lymphomaJamie D Croxtall
Pageof 5